Fig. 1

Flow diagram of corticosteroid-free induction therapy of 14 patients (a) and steroid-based induction therapy of 41 patients (b) with anti-HMGCR myopathy treated with a steroid-sparing immunosuppressant, with or without intravenous immunoglobulins